Keefe, Bruyette & Woods Increases Crescent Capital BDC (NASDAQ:CCAP) Price Target to $19.00

Crescent Capital BDC (NASDAQ:CCAP) had its target price hoisted by stock analysts at Keefe, Bruyette & Woods from $18.50 to $19.00 in a report issued on Thursday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Keefe, Bruyette & Woods’ target price indicates a potential upside of 6.03% from the stock’s current price.

A number of other equities research analysts have also commented on CCAP. Raymond James raised their price target on Crescent Capital BDC from $18.00 to $19.00 and gave the stock an “outperform” rating in a research report on Friday, May 10th. Oppenheimer raised their price target on Crescent Capital BDC from $18.00 to $19.00 and gave the stock an “outperform” rating in a research report on Friday, February 23rd. Finally, Wells Fargo & Company raised their price target on Crescent Capital BDC from $16.50 to $18.00 and gave the stock an “equal weight” rating in a research report on Monday, May 13th.

Crescent Capital BDC Trading Down 0.3 %

NASDAQ:CCAP opened at $17.92 on Thursday. Crescent Capital BDC has a 1-year low of $13.37 and a 1-year high of $18.20. The business’s 50-day moving average price is $17.40 and its two-hundred day moving average price is $17.00. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 1.11. The firm has a market capitalization of $664.12 million, a price-to-earnings ratio of 6.38 and a beta of 0.81.

Crescent Capital BDC (NASDAQ:CCAP) last released its earnings results on Wednesday, February 21st. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.57 by $0.04. Crescent Capital BDC had a return on equity of 11.99% and a net margin of 53.32%. The firm had revenue of $50.00 million for the quarter, compared to analyst estimates of $47.99 million. On average, equities analysts expect that Crescent Capital BDC will post 2.34 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of CCAP. Cape Investment Advisory Inc. bought a new position in shares of Crescent Capital BDC during the 4th quarter worth approximately $63,000. Tucker Asset Management LLC bought a new position in shares of Crescent Capital BDC during the 4th quarter worth approximately $167,000. SG Americas Securities LLC bought a new position in shares of Crescent Capital BDC during the 4th quarter worth approximately $197,000. Alpine Global Management LLC bought a new position in shares of Crescent Capital BDC during the 1st quarter worth approximately $217,000. Finally, Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Crescent Capital BDC during the 3rd quarter worth approximately $240,000. 49.46% of the stock is currently owned by institutional investors.

About Crescent Capital BDC

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.